Spatz3 Adjustable Balloon System

FDA Premarket Approval P190012 S003

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

DeviceSpatz3 Adjustable Balloon System
Generic NameImplant, Intragastric For Morbid Obesity
ApplicantSpatz FGIA Inc.1801 S Perimeter Rdsuite 130ft. Lauderdale, FL 33309 PMA NumberP190012 Supplement NumberS003 Date Received01/05/2023 Decision Date01/23/2023 Product Code LTI  Advisory Committee Gastroenterology/Urology Supplement Typespecial (immediate Track) Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No
Date Received2023-01-05
Decision Date2023-01-23
PMAP190012
SupplementS003
Product CodeLTI 
Advisory CommitteeGastroenterology/Urology
Supplement TypeSpecial (immediate Track)
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination ProductNo
Applicant AddressSpatz FGIA Inc.
1801 S Perimeter Rd
suite 130
ft. Lauderdale, FL 33309 PMA NumberP190012 Supplement NumberS003 Date Received01/05/2023 Decision Date01/23/2023 Product Code LTI  Advisory Committee Gastroenterology/Urology Supplement Typespecial (immediate Track) Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No Combination ProductNo Approval Order Statement  
Approval For The Spatz3 Adjustable Balloon System Is Indicated For Temporary Use For Weight Loss In Adults With Obesity Body Mass Index (BMI) Of 35.0-40.0 Kg/m2 Or A BMI Of 30.0 To 34.9 Kg/m2 With One Or More Major Obesity-related Comorbid Conditions Who Have Failed To Achieve And Maintain Weight-loss With A Supervised Weight Control Program. The Spatz3 Adjustable Balloon System Is To Be Used In Conjunction With A Long-term Supervised Diet And Behavior Modification Program Designed To Increase The Possibility Of Long-term Weight-loss Maintenance. The Maximum Placement Period For Spatz3 Adjustable Balloon System Is 8 Months.

Supplemental Filings

Supplement NumberDateSupplement Type
P190012Original Filing
S003 2023-01-05 Special (immediate Track)
S002
S001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.